The first female oral contraceptive was approved by the US Food and Drug Administration in 1960. In the 65 years since its inception, it has become a commonly used drug. The same cannot be said for ...

Use of injectable weight loss GLP-1 receptor agonists and the challenges this can pose when prescribing contraception or HRT ...

For many women, the pill has been a dependable part of life – a safeguard against unplanned pregnancy and, for some, a way of managing difficult periods or conditions such as endometriosis. It works ...

A potential new male contraceptive drug has just undergone its first tests in human volunteers. The results give the first indication that the drug, which does not use artificial hormones or affect ...

Tokyo, Oct. 20 (Jiji Press)--Japan's health ministry has approved the over-the-counter sale of emergency contraceptive pill Norlevo by Aska Pharmaceutical Co., the company said Monday. It is the ...

In the two years since the Roe decision was overturned, a great deal of ink has been spilled discussing new restrictions to abortion and other means of curtailing women’s reproductive choices. But now ...

Viral posts claim Trump banned Plan B One-Step pills made by Foundation Consumer Healthcare. The claim is false; no such ban or announcement exists. A claim has gone viral that President Donald Trump ...

Eli Lilly LLY announced positive top-line data from two late-stage studies evaluating orforglipron, its once-daily oral GLP-1 pill, in patients with type II diabetes (T2D). The ACHIEVE-2 study ...

Oct 15 (Reuters) - Eli Lilly's (LLY.N), opens new tab experimental weight-loss pill showed superior blood sugar control in diabetic patients across two late-stage trials, the company said on Wednesday ...

AVEO Oncology, an LG Chem company (AVEO), and HiberCell, Inc. (HiberCell) announced today that the companies have entered ...

PAGE ON ITS WEBSITE. WE’VE BEEN COVERING A BILL IN THE SOUTH CAROLINA LEGISLATURE THAT COULD FURTHER LIMIT A WOMAN’S ACCESS TO ABORTION AND PLACE CRIMINAL PENALTIES ON WOMEN AND MEDICAL PERSONNEL. AND ...

Gilead Sciences, Inc. will present new findings from its antiviral research and development programs at IDWeek, taking place October 19-22 in Atlanta, GA. Data from 34 presentations across HIV, ...